Big data on way to enabling 'zero defect' glass tubing

On the way to ‘zero defect’ glass tubing with 100,000 data tags/minute.
New perfeXion system, which generates around 100,000 data tags/min, makes an important contribution to quality assurance for downstream post-processing steps at the beginning of the value chain.
Schott is integrating a specially developed big data solution into its pharmaceutical tubing production, replacing statistical sample-based quality assurance with 100 percent on-line measurement. With the new IT-based process called perfeXion, process- and product-quality data of each individual glass tube is collected online and in real-time – an innovation that sets new standards in the pharmaceutical glass industry.
Making accurate glass tubes for the pharmaceutical industry is no light feat: at several metres per second, a virtually endless glass tube comes from the melt at over 1,600 °C and is drawn over a rotating mandrel. By making adjustments to the drawing speed and the air supply, wall thickness and tube diameter can be precisely determined down to the hundredth of a millimeter. A few metres further down the line, the cooled glass section is then cut into roughly 1.50-m-long pieces. From these glass tubes, converters can later manufacture pharmaceutical containers such as vials and syringes. Thanks to a unique big data approach, Schott is now able to measure 100% of every single glass tube in production. This data also enables for post-processing steps to be efficiently aligned with the tubing quality. With big data, the international technology group is creating a new industry standard and raising the quality of pharmaceutical glass production to a new level.
Instead of selecting a few glass tubes from each batch for statistical quality control, the new perfeXion system measures the entire glass tube many times over as it is drawn from the melt. Lasers recognize deviations in diameter and wall thickness, for example, and camera and IR inspection systems can even detect the smallest inclusions in the glass. Around 100,000 data tags are generated every minute. An integrated IT system, evaluating the continuous glass tube with real-time data measurements, calculates incidents of imperfection with such precision that it can later differentiate corresponding individual tubes which can then be sorted out. Each tube is checked again at its completion.
The system’s development took several years. Analysing a curved tube surface zooming down a production line was a particularly difficult challenge. The effort, however, has paid off – not least because the data analysis is a source of insight into how production can be further optimized.
Every year, Schott produces about 150,000 tons of glass tubing, most of which is destined for pharmaceutical packaging such as vials and syringes. Thanks to the new perfeXion approach, quality data can be traced back more detailed, not only by Schott but also the companies at subsequent steps in the value chain. “There comes a particular responsibility being a pharmaceutical industry supplier, and traceability is a major issue in the industry,” says Dr Patrick Markschläger, Executive Vice President at Schott Tubing. “By gathering information on each individual glass tube, we’ve already made an important contribution to quality assurance for downstream post-processing steps at the very beginning of the value chain.”
Related News
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease. -
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance